MA43596A1 - New peptides and novel combination of peptides for use in immunotherapy of esophageal cancer and other cancers - Google Patents

New peptides and novel combination of peptides for use in immunotherapy of esophageal cancer and other cancers

Info

Publication number
MA43596A1
MA43596A1 MA43596A MA43596A MA43596A1 MA 43596 A1 MA43596 A1 MA 43596A1 MA 43596 A MA43596 A MA 43596A MA 43596 A MA43596 A MA 43596A MA 43596 A1 MA43596 A1 MA 43596A1
Authority
MA
Morocco
Prior art keywords
peptides
relates
present
immunotherapy
cancers
Prior art date
Application number
MA43596A
Other languages
French (fr)
Inventor
Toni Weinschenk
Jens Fritsche
Colette Song
Harpreet Singh
Andrea Mahr
Oliver Schoor
Original Assignee
Immatics Biotechnologies Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immatics Biotechnologies Gmbh filed Critical Immatics Biotechnologies Gmbh
Priority to MA43596A priority Critical patent/MA43596A1/en
Publication of MA43596A1 publication Critical patent/MA43596A1/en

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La présente invention concerne des peptides, des protéines, des acides nucléiques et des cellules à utiliser dans des procédés immunothérapeutiques. La présente invention porte en particulier sur l'immunothérapie du cancer. La présente invention a également trait à des épitopes peptidiques de lymphocytes t associés à une tumeur, seuls ou combinés à d'autres peptides associés à une tumeur, qui peuvent par exemple servir en tant que principes actifs pharmaceutiques de compositions vaccinales qui stimulent des réponses immunitaires antitumorales, ou stimuler des lymphocytes t ex vivo afin de les transférer ensuite dans des patients. Des peptides liés aux molécules du complexe majeur d'histocompatibilité (cmh), ou des peptides en tant que tels, peuvent également être les cibles d'anticorps, de récepteurs de lymphocytes t solubles et d'autres molécules de liaison.The present invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. The present invention relates in particular to cancer immunotherapy. The present invention also relates to peptide epitopes of tumor associated t cells, alone or in combination with other tumor associated peptides, which can for example serve as pharmaceutical active ingredients in vaccine compositions which stimulate immune responses. antitumor, or stimulate ex vivo T lymphocytes in order to transfer them to patients. Peptides bound to major histocompatibility complex (cmh) molecules, or peptides as such, can also be the targets of antibodies, soluble T cell receptors and other binding molecules.

MA43596A 2018-10-26 2018-10-26 New peptides and novel combination of peptides for use in immunotherapy of esophageal cancer and other cancers MA43596A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MA43596A MA43596A1 (en) 2018-10-26 2018-10-26 New peptides and novel combination of peptides for use in immunotherapy of esophageal cancer and other cancers

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MA43596A MA43596A1 (en) 2018-10-26 2018-10-26 New peptides and novel combination of peptides for use in immunotherapy of esophageal cancer and other cancers

Publications (1)

Publication Number Publication Date
MA43596A1 true MA43596A1 (en) 2021-04-30

Family

ID=75687907

Family Applications (1)

Application Number Title Priority Date Filing Date
MA43596A MA43596A1 (en) 2018-10-26 2018-10-26 New peptides and novel combination of peptides for use in immunotherapy of esophageal cancer and other cancers

Country Status (1)

Country Link
MA (1) MA43596A1 (en)

Similar Documents

Publication Publication Date Title
MA42381B1 (en) New peptides and novel peptide combination for use in immunotherapy of esophageal cancer and other cancers
MA46508A1 (en) New cell epitopes and novel combination of cell epitopes for use in immunotherapy of myeloma and other cancers
MA43090A1 (en) Peptides, peptide combinations and cell-based drugs for immunotherapy against urinary bladder cancer and other cancers
MA43490A1 (en) New peptides and combination of peptides for use in immunotherapy against various cancers
MA43330B1 (en) Transfected T cells and T cell receptors for use in immunotherapy against cancers
MA46647A1 (en) New peptides and combination of peptides for use in immunotherapy of pancreatic cancer and other cancers
MA44101B1 (en) Peptides and combination of peptides for use in immunotherapy against breast cancer and other cancers
MA46022B1 (en) New peptides and peptide combination for use in immunotherapy against prostate cancer and other cancers
MA43461A1 (en) Novel peptides, peptide combinations and carriers for use in the immunotherapeutic treatment of various cancers
MA43328A1 (en) Transfected t-cells and t-cell receptors for use in immunotherapy against cancers
MA41520B2 (en) New peptides and peptide combination for use in immunotherapy against ovarian cancer and other cancers
MA43327A1 (en) Peptides and peptide combination for use in immunotherapy against non-small cell lung cancer and other cancers
MA44551A1 (en) Novel peptides and novel combination of peptides for use in immunotherapy, and methods for generating scaffolds for use against pancreatic cancer and other cancers
MA43435B1 (en) NEW PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS (SEQ ID 25 - MRAX5-003)
MA42294B1 (en) New peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
MA42045A (en) NEW PEPTIDES AND COMBINATIONS OF PEPTIDES AND SCAFFOLDING FORMED THEREOF FOR USE IN IMMUNOTHERAPY AGAINST COLORECTAL CARCINOMA (CRC) AND OTHER CANCERS
MA41237B1 (en) New peptides and peptide combinations for use in immunotherapy against hepatocellular carcinoma (chc) and other cancers
MA47367B1 (en) NOVEL PEPTIDES AND COMBINATIONS OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST OVARIAN CANCER AND OTHER CANCERS
MA43596A1 (en) New peptides and novel combination of peptides for use in immunotherapy of esophageal cancer and other cancers
MA46503A1 (en) New cell epitopes and novel combination of cell epitopes for use in immunotherapy of myeloma and other cancers
MA41664A1 (en) Novel peptides and novel peptide combination for use in immunotherapy, and methods for generating scaffolds for use against pancreatic cancer and other cancers
EA202191411A1 (en) IMMUNOTHERAPY OF CANCER DISEASES RESTRICTED ON B * 08 PEPTIDES AND COMBINATIONS OF PEPTIDES AND RELATED METHODS